NOVOCURE LIMITED

(NVCR)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
73.30 USD   +5.47%
07/01Novocure to Report Second Quarter 2022 Financial Results
BU
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Index
CI
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Growth Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on NOVOCURE LIMITED
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
04/04Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Ratin..
MT
02/08Loop Capital Starts NovoCure at Buy With $200 Price Target
MT
02/02Oppenheimer Upgrades NovoCure to Outperform From Perform; Price Target is $98
MT
01/20Truist Securities Upgrades NovoCure to Buy from Hold, Keeps $125 Price Target
MT
01/11Wells Fargo Adjusts NovoCure's Price Target to $70 From $105, Keeps Equalweight Rating
MT
01/10Wedbush Cuts NovoCure's Price Target to $45 From $85, Says 'Revenues Have Flat-Lined;' ..
MT
01/06Piper Sandler Adjusts NovoCure's Price Target to $130 From $180, Reiterates Overweight ..
MT
01/03Evercore ISI Upgrades NovoCure to In-Line From Underperform; Keeps Price Target at $82
MT
2021Wedbush Adjusts Price Target for NovoCure to $85 From $101, Maintains Underperform Rati..
MT
2021NOVOCURE : Wedbush Adjusts NovoCure PT to $101 From $148, Maintains Underperform Rating
MT
2021NOVOCURE : Wells Fargo Adjusts Price Target on NovoCure to $180 From $215, Maintains Equal..
MT
2021NOVOCURE : Mizuho Securities Adjusts NovoCure's Price Target to $200 From $229, Maintains ..
MT
2021NOVOCURE : Piper Sandler Adjusts NovoCure's Price Target to $240 From $235, Reiterates Ove..
MT
2021NOVOCURE : Mizuho Securities Cuts NovoCure to Neutral From Buy, Price Target to $229 From ..
MT
2021NOVOCURE : Wedbush Lowers NovoCure's Price Target to $148 From $154 on Optune Revenue Expe..
MT
2021NOVOCURE : Truist Securities Adjusts Price Target on NovoCure to $142 From $132, Maintains..
MT
2021NOVOCURE : JP Morgan Adjusts NovoCure PT to $172 From $103, Maintains Neutral Rating
MT
2021NOVOCURE : Northland Capital Adjusts NovoCure's Price Target to $250 from $200, Keeps Outp..
MT
2021NOVOCURE : Mizuho Adjusts NovoCure's Price Target to $242 From $175, Maintains Buy Rating
MT
2021NOVOCURE : Wedbush Cuts NovoCure to Underperform From Neutral, PT to $154 From $159 on Ass..
MT
2021NOVOCURE : Wells Fargo Adjusts NovoCure PT to $215 From $135, Maintains Equal Weight Ratin..
MT
2021NOVOCURE : Mizuho Adjusts Price Target on NovoCure to $175 From $150, Maintains Buy Rating
MT
2021NOVOCURE : Wedbush Adjusts NovoCure's Price Target to $159 From $110, Maintains Neutral Ra..
MT
Upcoming event on NOVOCURE LIMITED